Literature DB >> 16905887

Mobility limitations and cognitive deficits as predictors of institutionalization among community-dwelling older people.

Mikaela von Bonsdorff1, Taina Rantanen, Pia Laukkanen, Timo Suutama, Eino Heikkinen.   

Abstract

PURPOSE: Mobility limitations and cognitive disorders have often been observed as risks for institutionalization. However, their combined effects on risk of institutionalization among initially community-dwelling older people have been less well reported.
DESIGN: A prospective cohort study with 10-year surveillance on institutionalization.
SUBJECTS: Study population (n = 476) consisted of 75- and 80-year-old people who were community-dwelling, had not been diagnosed with dementia, and participated in tests on walking speed and cognitive capacity at a research centre. MEASURES: Cognitive capacity was measured with three validated psychometric tests that were from the Wechsler Adult Intelligence Scale, Wechsler Memory Scale and Schaie-Thurstone Adult Mental Abilities Test. Mobility was measured with walking speed over a 10-m distance. Exclusive distribution based study groups were formed with cut-offs at the lowest third as follows: no limitation, solely mobility limitation, solely cognitive deficits, and combined mobility limitation and cognitive deficits. Cox proportional hazards model was used to determine the relative risks of institutionalization for the study groups.
RESULTS: Eleven percent of the participants were institutionalized during the 10-year surveillance. The risk for institutionalization was 4.9 times greater (95% confidence interval: 2.1-11.2) for those who had co-existing mobility limitations and cognitive deficits than for those with no limitations.
CONCLUSIONS: The findings show that the accumulation of limitations in physical and cognitive performance substantially decreases the possibility for a person remaining at home. This might be due to a decreased reserve capacity and ineffective compensatory strategies. Therefore, interventions targeted to improve even one limitation, or prevent accumulation of these risk factors, could significantly reduce the risk of institutionalization. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16905887     DOI: 10.1159/000094985

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  36 in total

1.  Genetic and environmental factors impact age-related impairment of negative geotaxis in Drosophila by altering age-dependent climbing speed.

Authors:  Devin Rhodenizer; Ian Martin; Poonam Bhandari; Scott D Pletcher; Mike Grotewiel
Journal:  Exp Gerontol       Date:  2008-04-27       Impact factor: 4.032

2.  Adverse events associated with testosterone administration.

Authors:  Shehzad Basaria; Andrea D Coviello; Thomas G Travison; Thomas W Storer; Wildon R Farwell; Alan M Jette; Richard Eder; Sharon Tennstedt; Jagadish Ulloor; Anqi Zhang; Karen Choong; Kishore M Lakshman; Norman A Mazer; Renee Miciek; Joanne Krasnoff; Ayan Elmi; Philip E Knapp; Brad Brooks; Erica Appleman; Sheetal Aggarwal; Geeta Bhasin; Leif Hede-Brierley; Ashmeet Bhatia; Lauren Collins; Nathan LeBrasseur; Louis D Fiore; Shalender Bhasin
Journal:  N Engl J Med       Date:  2010-06-30       Impact factor: 91.245

3.  Associations between physical performance and executive function in older adults with mild cognitive impairment: gait speed and the timed "up & go" test.

Authors:  Ellen L McGough; Valerie E Kelly; Rebecca G Logsdon; Susan M McCurry; Barbara B Cochrane; Joyce M Engel; Linda Teri
Journal:  Phys Ther       Date:  2011-05-26

4.  Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study.

Authors:  Joanne B Krasnoff; Shehzad Basaria; Michael J Pencina; Guneet K Jasuja; Ramachandran S Vasan; Jagadish Ulloor; Anqi Zhang; Andrea Coviello; Margaret Kelly-Hayes; Ralph B D'Agostino; Philip A Wolf; Shalender Bhasin; Joanne M Murabito
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

5.  Wheeled-mobility correlates of life-space and social participation in adult manual wheelchair users aged 50 and older.

Authors:  Brodie M Sakakibara; François Routhier; William C Miller
Journal:  Disabil Rehabil Assist Technol       Date:  2016-07-04

6.  Slow Gait Speed and Risk of Long-Term Nursing Home Residence in Older Women, Adjusting for Competing Risk of Mortality: Results from the Study of Osteoporotic Fractures.

Authors:  Jennifer G Lyons; Kristine E Ensrud; John T Schousboe; Charles E McCulloch; Brent C Taylor; Timothy C Heeren; Sherri O Stuver; Lisa Fredman
Journal:  J Am Geriatr Soc       Date:  2016-11-22       Impact factor: 5.562

7.  The influence of walkability on broader mobility for Canadian middle aged and older adults: An examination of Walk Score™ and the Mobility Over Varied Environments Scale (MOVES).

Authors:  Jana A Hirsch; Meghan Winters; Philippa J Clarke; Nathalie Ste-Marie; Heather A McKay
Journal:  Prev Med       Date:  2016-10-01       Impact factor: 4.018

8.  Obesity and late-age survival without major disease or disability in older women.

Authors:  Eileen Rillamas-Sun; Andrea Z LaCroix; Molly E Waring; Candyce H Kroenke; Michael J LaMonte; Mara Z Vitolins; Rebecca Seguin; Christina L Bell; Margery Gass; Todd M Manini; Kamal H Masaki; Robert B Wallace
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

9.  Predictors of nursing home admission of individuals without a dementia diagnosis before admission - results from the Leipzig Longitudinal Study of the Aged (LEILA 75+).

Authors:  Melanie Luppa; Tobias Luck; Herbert Matschinger; Hans-Helmut König; Steffi G Riedel-Heller
Journal:  BMC Health Serv Res       Date:  2010-06-29       Impact factor: 2.655

10.  New Institutionalization in Long-Term Care After Hospital Discharge to Skilled Nursing Facility.

Authors:  Addie Middleton; Shuang Li; Yong-Fang Kuo; Kenneth J Ottenbacher; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2017-11-07       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.